​Covers principles and operation of the Sherman Act, Clayton Act and Federal Trade Commission Act and their effect upon conduct, as opposed to structure, of American industry. Examines issues of price fixing, boycotts, exclusive dealing, territorial allocation, tie-ins, franchise terminations, and governmental immunity for anti-competitive regulations.

​Explores bioethics issues such as clinical decision making, informed consent, organ donation and transplantation, physician assisted suicide, ethics in managed care, death and dying, and medical research.

​Refers to a collection of statutory and common law recognized causes of action that arise out of business competition. Surveys these causes of action and analyzes them in the context of providing a source of protection to a business which is subject to potential economic harm from competitors, employees, suppliers, and others. Coverage will include false advertising, business defamation and disparagement, interference with contractual and prospective business relationships, misappropriation of trade values such as ideas, trade secrets, publicity rights, and misrepresentation. Prohibitions against unfair and deceptive practices under the Federal Trade Commission Act will also be covered. Trademark issues fall outside the coverage of this course. Not open to students who have taken Unfair Trade Practices.

​Describes the medico-legal paradigm within which genetic technologies are presently pursued or restricted. Discusses the scientific basis of the genetic technologies providing students with basic appreciation of potential issues and a guide to the scientific, rather than the legal, literature related to the growing area of genomics. The course will be organized along six areas of the law: criminal law, family and property law, tort law, insurance law, labor law, and intellectual property law. No science background is required.